These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2479578)

  • 21. [Modeling antigenic determinants of the hepatitis A virus using synthetic peptides].
    Kulik LN; Ivanov VS; Chikin LD; Berkova NP; Kozhich AT; Gabriélian AE; Ivanova VT
    Bioorg Khim; 1994 Jul; 20(7):709-19. PubMed ID: 7527634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mimicry of the immunodominant conformation-dependent antigenic site of hepatitis A virus by motifs selected from synthetic peptide libraries.
    Mattioli S; Imberti L; Stellini R; Primi D
    J Virol; 1995 Sep; 69(9):5294-9. PubMed ID: 7543581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of a foreign epitope on the surface of the adenovirus hexon.
    Crompton J; Toogood CI; Wallis N; Hay RT
    J Gen Virol; 1994 Jan; 75 ( Pt 1)():133-9. PubMed ID: 7509367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antigenic epitopes of the hepatitis A virus polyprotein.
    Khudyakov YE; Lopareva EN; Jue DL; Fang S; Spelbring J; Krawczynski K; Margolis HS; Fields HA
    Virology; 1999 Aug; 260(2):260-72. PubMed ID: 10417261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Addition of a foreign oligopeptide to the major capsid protein of poliovirus.
    Colbère-Garapin F; Christodoulou C; Crainic R; Garapin AC; Candrea A
    Proc Natl Acad Sci U S A; 1988 Nov; 85(22):8668-72. PubMed ID: 2460875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant polioviruses as candidate strains of oral poliovaccines.
    Nomoto A
    Dev Biol Stand; 1995; 84():123-7. PubMed ID: 7796944
    [No Abstract]   [Full Text] [Related]  

  • 27. Manipulation of the cellular binding properties of poliovirus: implications for non-target effects of recombinant vaccines.
    Whelan SP; Evans D; Almond JW
    Dev Biol Stand; 1995; 84():129-36. PubMed ID: 7796945
    [No Abstract]   [Full Text] [Related]  

  • 28. A recombinant vaccinia virus expressing hepatitis A virus structural polypeptides: characterization and demonstration of protective immunogenicity.
    Karayiannis P; O'Rourke S; McGarvey MJ; Luther S; Waters J; Goldin R; Thomas HC
    J Gen Virol; 1991 Sep; 72 ( Pt 9)():2167-72. PubMed ID: 1654376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of a monoclonal antibody and of DNA recombinant technology for the localization of a poliovirus neutralization epitope in viral capsid polypeptide VP1.
    Bruneau P; van der Werf S; Wychowski C; Siffert O; Girard M
    Dev Biol Stand; 1984; 57():177-85. PubMed ID: 6084609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and characterization of a cross-neutralization epitope of Enterovirus 71.
    Liu CC; Chou AH; Lien SP; Lin HY; Liu SJ; Chang JY; Guo MS; Chow YH; Yang WS; Chang KH; Sia C; Chong P
    Vaccine; 2011 Jun; 29(26):4362-72. PubMed ID: 21501643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary structure and gene organization of human hepatitis A virus.
    Najarian R; Caput D; Gee W; Potter SJ; Renard A; Merryweather J; Van Nest G; Dina D
    Proc Natl Acad Sci U S A; 1985 May; 82(9):2627-31. PubMed ID: 2986127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antigenic and immunogenic properties of a hepatitis A virus capsid protein expressed in Escherichia coli.
    Johnston JM; Harmon SA; Binn LN; Richards OC; Ehrenfeld E; Summers DF
    J Infect Dis; 1988 Jun; 157(6):1203-11. PubMed ID: 2836522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of the immunogenicity of a synthetic peptide bearing a VP3 epitope of hepatitis A virus.
    Pintó RM; González-Dankaart JF; Sánchez G; Guix S; Gómara MJ; García M; Haro I; Bosch A
    FEBS Lett; 1998 Oct; 438(1-2):106-10. PubMed ID: 9821968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Localization of a poliovirus type 1 neutralization epitope in viral capsid polypeptide VP1.
    van der Werf S; Wychowski C; Bruneau P; Blondel B; Crainic R; Horodniceanu F; Girard M
    Proc Natl Acad Sci U S A; 1983 Aug; 80(16):5080-4. PubMed ID: 6308670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Presentation of foreign antigenic determinants at the bacterial cell surface using the TraT lipoprotein.
    Harrison JL; Taylor IM; O'Connor CD
    Res Microbiol; 1990; 141(7-8):1009-12. PubMed ID: 1714091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Negative selection on neutralization epitopes of poliovirus surface proteins: implications for prediction of candidate epitopes for immunization.
    Suzuki Y
    Gene; 2004 Mar; 328():127-33. PubMed ID: 15019992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Approaches to the development of new poliovirus vaccines based on molecular genetics.
    Nomoto A; Toyoda H; Kataoka Y; Kohara M; Suganuma T; Omata T; Imura N
    Rev Infect Dis; 1984; 6 Suppl 2():S494-8. PubMed ID: 6330845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular consistency monitoring of oral poliovirus vaccine and other live viral vaccines.
    Chumakov KM
    Dev Biol Stand; 1999; 100():67-74. PubMed ID: 10616177
    [No Abstract]   [Full Text] [Related]  

  • 39. Mutations in the poliovirus P1 capsid precursor at arginine residues VP4-ARG34, VP3-ARG223, and VP1-ARG129 affect virus assembly and encapsidation of genomic RNA.
    Ansardi DC; Luo M; Morrow CD
    Virology; 1994 Feb; 199(1):20-34. PubMed ID: 8116243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the use of non-pathogenic porcine circovirus type 1 as a vaccine delivery virus vector to express antigenic epitopes of porcine reproductive and respiratory syndrome virus.
    Piñeyro PE; Kenney SP; Giménez-Lirola LG; Opriessnig T; Tian D; Heffron CL; Meng XJ
    Virus Res; 2016 Feb; 213():100-108. PubMed ID: 26555162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.